Print this page

Public Release Summary on the evaluation of the new active zilpaterol hydrochloride in the product Zilmax Medicated Premix

Type
Public Release Summary (PRS)
Publication date
ISSN electronic
1443-1335
At the request of stakeholders, we have extended the consultation closing date to 23 June 2020.

Content last updated

Content last reviewed

URL

http://apvma.gov.au/node/67761
Was this page helpful?

Your feedback will be submitted to the APVMA anonymously. If you require a response, please contact us.

CAPTCHA